| 1 | 22869149 | LMTK3 is implicated in endocrine resistance via multiple signaling pathways. | Oncogene | 2013 Jul 11 |
4 |
| 2 | 24619340 | Structural modeling and molecular dynamics studies on the human LMTK3 domain and the mechanism of ATP binding. | Mol Biosyst | 2014 May |
6 |
| 3 | 24695631 | Lemur tyrosine kinase-3 is a significant prognostic marker for patients with colorectal cancer. | Int J Clin Exp Pathol | 2014 |
1 |
| 4 | 27056562 | Designing and optimization of novel human LMTK3 inhibitors against breast cancer - a computational approach. | J Recept Signal Transduct Res | 2017 Feb |
6 |
| 5 | 29540829 | LMTK3 confers chemo-resistance in breast cancer. | Oncogene | 2018 Jun |
8 |
| 6 | 29719770 | Identification of curcumin derivatives as human LMTK3 inhibitors for breast cancer: a docking, dynamics, and MM/PBSA approach. | 3 Biotech | 2018 May |
7 |
| 7 | 30066129 | Structure-Based Virtual Screening of High-Affinity ATP-Competitive Inhibitors Against Human Lemur Tyrosine Kinase-3 (LMTK3) Domain: A Novel Therapeutic Target for Breast Cancer. | Interdiscip Sci | 2019 Sep |
8 |
| 8 | 30944027 | The lncRNA MIR2052HG regulates ERĪ± levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1. | Breast Cancer Res | 2019 Apr 3 |
2 |
| 9 | 31223209 | Molecular screening and docking analysis of LMTK3and AKT1 combined inhibitors. | Bioinformation | 2018 |
1 |
| 10 | 32192797 | Discovery of cyclic guanidine-linked sulfonamides as inhibitors of LMTK3 kinase. | Bioorg Med Chem Lett | 2020 May 1 |
2 |
| 11 | 32865871 | LMTK3 promotes tumorigenesis in bladder cancer via the ERK/MAPK pathway. | FEBS Open Bio | 2020 Oct |
3 |